340B Provider Reforms Gaining Momentum In Congress
House Energy & Commerce Committee recommends more oversight of hospital participation in the 340B drug discount program.
You may also be interested in...
Getting seven top pharma leaders in the same room, required to answer tough questions on drug pricing, is rare. Members of the Senate Finance Committee got that opportunity recently, but there are some questions our Pink Sheet reporters think they missed.
Energy & Commerce Health Subcommittee releases several discussion drafts at hearing on 340B drug discount program reform as the debate seems poised to move into the next phase.
House Energy and Commerce Committee releases US Government Accountability Office analysis of 340B contract pharmacies.